首页 依特钠(usAEZS)-基本信息

依特钠(usAEZS)-基本信息

日报更新时间:07-02 06:53

周报更新时间:01-23 11:54

行情信息

今开价:

最高价:

成交量:

昨收价:

最低价:

最新价:

行情图标
概要信息

中文名称:依特钠


英文名称:AEterna Zentaris


行业:医疗


简介:Aeterna Zentaris Inc.于1990年9月12日 ,在Canada Business Corporations Act名下成立,并继续受其管理


电话:1-843-9003211,1-843-9003223


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 持股信息
  • 领导人信息

Aeterna Zentaris Inc. 是一家开发肿瘤治疗及内分泌疾病治疗药物的生物制药公司,依特钠公司旗下产品有: MACRILEN——用于生长激素缺乏症,同时增加治疗诱发癌症恶病质,目前处于IIa临床试验阶段; ZoptEC——用于子宫内膜癌,目前处于治疗复发或转移性子宫内膜癌III期临床试验阶段; AEZS-120——重组口腔肿瘤疫苗,目前处于临床前阶段; PI3K/ ERK抑制剂AEZS-129和AEZS-136; disora​​zol Z产品AEZS-137和AEZS-138。

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Dimensional Fund Advisors Canada Inc 6207 0.04% -- -- 2019-07-31
Susquehanna International Group, LLP 67841 0.41% 35490 109.70% 2019-03-31
Susquehanna Financial Group, LLLP 67841 0.41% 35490 109.70% 2019-03-31
Renaissance Technologies Corp 110078 0.67% 77000 232.78% 2019-03-31
Acadian Asset Management LLC 167222 1.02% 167222 -- 2019-03-31
EAM Investors, LLC 171019 1.04% 171019 -- 2019-03-31
ARONSON+JOHNSON+ORTIZ 221614 1.35% 221614 -- 2019-03-31
J. Goldman & Co LP 374000 2.27% -623494 -62.51% 2019-03-31
Morgan Stanley - Brokerage Accounts 702277 4.27% -5137 -0.73% 2019-03-31
Hillsdale Investment Management Inc. 63100 0.38% 36900 140.84% 2019-03-31
BOOTHBAY FUND MANAGEMENT, LLC 45853 0.28% -- -- 2019-03-31
BlackRock Fund Advisors 41392 0.25% -- -- 2019-07-31
Russell Investments Canada Limited 8384 0.05% -968 -10.35% 2019-07-31
Dimensional Fund Advisors LP 18110 0.11% -- -- 2019-07-31
Fidelity Management & Research Company 23853 0.15% 3449 16.90% 2019-07-31
O'Shaughnessy Asset Management LLC 25051 0.15% 2520 11.18% 2019-03-31
GuideStone Capital Management, LLC 26566 0.16% -4015 -13.13% 2019-07-31
Citadel Advisors Llc 28493 0.17% 28493 -- 2019-03-31
Morgan Stanley Canada Ltd. 31500 0.19% -- -- 2019-03-31
Virtu Financial LLC 38480 0.23% 38480 -- 2019-03-31
S¨?nchez Casas Asesores EAFI 8800 0.05% -- -- 2019-07-31
Deutsche Bank AG 24000 0.15% 1989 9.04% 2018-12-31
Anson Funds Management LP 335781 2.04% 335781 -- 2018-12-31
Ardsley Advisory Partners 25000 0.15% 25000 -- 2018-12-31
Morgan Stanley Smith Barney LLC 10374 0.06% 7573 270.37% 2018-12-31
JANE STREET GROUP, LLC 10073 0.06% 10073 -- 2018-12-31
Hillsdale Investment Management 26200 0.16% 26200 -- 2019-05-31
Bridgeway Capital Management, Inc 111000 0.68% 111000 -- 2018-12-31
Guidestone Capital Management 30581 0.19% 30581 -- 2019-04-30
Lake Street Risk Retention Group Inc 111000 0.68% 111000 -- 2018-12-31
J.P. Morgan Securities Inc 80900 0.49% 1000 1.25% 2018-09-30
JPMorgan Chase & Co 80900 0.49% 1000 1.25% 2018-09-30
Truvestments Capital LLC 4369 0.03% 4369 -- 2018-09-30
Vassalluzzo Scott J 11438 0.07% 11438 -- 2018-09-30
UBS Group AG 1036 0.01% -12645 -92.43% 2018-12-31
Ballew Advisors, Inc 3000 0.02% 3000 -- 2018-09-30
Royal Bank of Canada 601 -- 601 -- 2018-09-30
Wells Fargo & Co 800 -- -- -- 2018-09-30
Citigroup Inc 1000 0.01% -- -- 2018-09-30
Cutler Group LP 900 0.01% -- -- 2018-06-30
Jnba Financial Advisors Inc 91 -- -- -- 2018-06-30
The Toronto-Dominion Bank 438 -- 438 -- 2018-09-30
Morgan Stanley & Co Inc 215666 1.31% 108400 101.06% 2018-06-30
Wells Fargo Advisors, LLC 800 -- -- -- 2018-09-30
UBS Securities LLC 585 -- 585 -- 2018-06-30
Bank of Montreal 45 -- 1 2.27% 2018-09-30
Millennium Management LLC -- -- -10553 -100.00% 2018-09-30
Bank of America Corporation 369 -- 359 3590.00% 2018-03-31
SIMPLEX TRADING, LLC 276 -- -7061 -96.24% 2018-03-31
Advisor Group, Inc. 13 -- 13 -- 2018-03-31
Ladenburg Thalmann Asset Management Inc 3 -- -- -- 2018-06-30
Merrill Lynch & Co Inc 10 -- 10 -- 2018-06-30
BMO Asset Management Inc 44 -- -- -- 2018-06-30
Stratos Wealth Partners, LTD 16 -- 16 -- 2018-03-31
Brandes Investment Partners & Co 34000 0.21% 34000 -- 2017-12-31
TWO SIGMA SECURITIES, LLC 16322 0.10% -10293 -38.67% 2017-12-31
Tower Research Capital LLC 1397 0.01% 1397 -- 2017-09-30
Group One Trading, LP 14670 0.09% 14670 -- 2017-09-30
Nine Chapters Capital Management LLC 18500 0.11% 18500 -- 2017-09-30
Private Advisor Group, LLC 20501 0.13% 20501 -- 2017-09-30
Springbok Capital Management, LLC 10700 0.07% 9700 970.00% 2017-09-30
DAVENPORT vermogensbeheer 250 -- -- -- 2016-10-31
Bt Alex Brown Inc 11900 0.08% -28900 -70.83% 2017-06-30
KCG AMERICAS LLC 18577 0.13% 450 2.48% 2017-06-30
Sabby Management LLC 67283 0.47% 67283 -- 2017-06-30
Metlife Securities Inc 12 -- -- -- 2016-09-30
Creative Planning Inc 5015 0.05% 4990 19960.00% 2016-09-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
iShares Micro-Cap ETF 41392 0.25% -- -- 2019-07-30
Bridgeway Ultra Small Company Fund -- -- -111000 -100.00% 2019-03-31
Maverick Fund FI -- -- -8800 -100.00% 2019-07-31
DFA Global Small Company Portfolio 5 -- -- -- 2019-05-31
NT Quality SCC Global Fund - Non-Lending 1144 0.01% 1144 -- 2019-06-30
NT Quality SCC International Fund - NL 1144 0.01% 1144 -- 2019-06-30
Hillsdale Canadian Small Cap Equity Fund 1925 0.01% 1925 -- 2018-12-31
Brighthouse/Dimensional Intl Sm Cm Port 2400 0.01% -- -- 2019-06-30
DFA World ex US Core Equity Portfolio 2600 0.02% -- -- 2019-05-31
JHancock International Small Company Fd 4400 0.03% -- -- 2019-05-31
DFA International Small Company Port 4966 0.03% -- -- 2019-06-30
DFA International Small Cap Growth Portf 5039 0.03% -- -- 2019-06-30
DFA TA World ex US Core Equity Port 5500 0.03% -- -- 2019-05-31
DFA Canadian Vector Equity Fund 6207 0.04% -- -- 2019-05-31
Russell Inv US Equity Pool 8384 0.05% -968 -10.35% 2019-05-31
Hillsdale Global Small Cap Equity Fund 17155 0.10% 17155 -- 2018-12-31
Fidelity 23853 0.15% 3449 16.90% 2019-06-30
GuideStone Funds Small Cap Equity Fund 26566 0.16% -4015 -13.13% 2019-06-30
Hillsdale US Small Cap Equity Fund -- -- -26200 -100.00% 2019-03-31

Philip A. Theodore Mr. Philip A. Theodore is Secretary & General Counsel at Medizone International, Inc. and Secretary, Chief Administrative Officer & SVP at �0�1�6�9terna Zentaris, Inc. Mr. Theodore was previously employed as Secretary, Vice President & General Counsel by Zep, Inc., VP-Corporate Development, Compliance & Legal by BioReliance Corp., General Counsel by CryoLife, Inc., General Counsel & Senior Vice President by John H. Harland Co., Secretary, Vice President & General Counsel by Serologicals Corp., and a Principal by King & Spalding LLP. He received his undergraduate degree from the University of Tennessee and a graduate degree from Uc College of Law.
James Clavijo James Clavijo founded Capital View Partners, Inc. Presently, he is Chief Financial Officer of Real Brands, Inc., Chief Financial Officer of Ventumar SA, Chief Financial Officer for Tri-Source Pharma LLC and Chief Financial Officer at �0�1�6�9terna Zentaris, Inc. In the past James Clavijo was Chief Financial Officer for Gallery Industries, Inc., Chief Financial Officer for Guided Therapeutics, Inc., Chief Financial Officer & Managing Partner at Capital View Partners, Inc., Senior Vice President-Finance at BioNitrogen Holdings Corp., Chief Accounting Officer & Controller of Soligenix, Inc., Chief Financial Officer of Bluvision, Inc., Finance Manager at G4S Secure Solutions (USA), Inc., Chief Financial Officer of Cigarette Racing Team LLC and Corporate Controller at A Novo Broadband, Inc. James Clavijo received a graduate degree from Florida International University, an undergraduate degree from the University of Nebraska and an undergraduate degree from the University of Florida.
David A. Dodd Mr. David A. Dodd is a Chief Executive Officer & Director at Medizone International, Inc., a Chairman at GeoVax Labs, Inc. and a Chief Executive Officer at Vaxygen Holdings LLC. He is on the Board of Directors at Medizone International, Inc. and �0�1�6�9terna Zentaris, Inc. Mr. Dodd was previously employed as a Chairman, President & Chief Executive Officer by BioReliance Corp., a Non-Executive Chairman by Stem Cell Sciences Plc, a President, Chief Executive Officer & Director by Serologicals Corp., a Chairman by Unimed Pharmaceuticals, Inc., a President & Chief Executive Officer by Solvay Pharmaceuticals, Inc., a Principal by Abbott Laboratories, a Chairman by American Foundation for Suicide Prevention, a Principal by Bristol-Myers Squibb Co., a Chairman by Georgia Bio, a Chief Executive Officer by RiversEdge BioVentures LLC, a Member-Management Board by Solvay SA, a Non-Executive Director by Stheno Corp., and a Principal by Wyeth-Ayerst Laboratories. He also served on the board at Sierra Leone Diamond Co. Ltd., ArunA Biomedical, Inc. and PNP Therapeutics, Inc. He received his undergraduate degree from Georgia State University and a graduate degree from Georgia State University.
Michael A. Cardiff Michael A. Cardiff holds the position of Chief Executive Officer at Accelerents, Inc. He is also Member of Institute of Corporate Directors and on the board of 9 other companies. Mr. Cardiff previously occupied the position of Chief Executive Officer of Imperial Capital Group Ltd., President & Chief Executive Officer at Fincentric Corp., President & Chief Executive Officer for INEA Corp., National Vice President-General Business at SAP Canada, Inc., Senior Vice President for Infor (Canada) Ltd. and Executive Vice President-Financial Services at EDS Canada, Inc.
G�0�1�0�8rard Antoine Limoges G�0�1�0�8rard Antoine Limoges is on the board of �0�1�6�9terna Zentaris, Inc., PRO Real Estate Investment Trust, Montreal Symphony Orchestra, Inc. and Hartco, Inc. and Member of Institute of Corporate Directors, Member of Ordre des administrateurs agr�0�1�0�8�0�1�0�8s du Qu�0�1�0�8bec, Member of Ordre des comptables professionnels agr�0�1�0�8�0�1�0�8s du Qu�0�1�0�8bec, Member of Chartered Professional Accountants of Quebec and Member of Canadian Institute of Chartered Accountants. Mr. Limoges previously held the position of Chairman of Genizon Biosciences, Inc., Deputy Chairman at Ernst & Young LLP (Canada), Chairman of Institut de Recherches Cliniques de Montr�0�1�0�8al and Chairman at Fellowship of Christian Athletes. G�0�1�0�8rard Antoine Limoges received an undergraduate degree from the University of Montr�0�1�0�8al.
Eckhard G. Guenther Mr. Kenneth E. Newport is Chairman at Ottawa Life Sciences Council, Chairman at Ottawa Hospital Research Institute, and a Member at Institute of Corporate Directors. He is on the Board of Directors at �0�1�6�9terna Zentaris, Inc., Jennerex Biotherapeutics, Inc., and MedGenesis Therapeutix, Inc. Mr. Newport was previously employed as Independent Director by Nordion, Inc., Independent Director by OPMEDIC Group, Inc., Senior VP-Worldwide Business Development by Nordion, Inc., President by CroMedica International, Inc., Founding Member by Global Biomedical Capital Corp., Founding Member by Prime Trials Ltd., Founding Member by Azelon Pharmaceuticals, Inc., and Senior Vice President by Pinnacle Holdco Parent, Inc. He also served on the board at MDS Nordion, Inc. He received his undergraduate degree from The University of Waterloo and a graduate degree from The University of Waterloo.
Jonathan M. Pollack Presently, Jonathan M. Pollack is President for JMP Fam Holdings, Inc., Chief Financial Officer & Secretary at KAB Distribution, Inc., Chief Financial Officer & Director at Babyzone.com, Inc. (a subsidiary of KAB Distribution, Inc.), Chief Financial Officer at AcuityAds Holdings, Inc. and Director-Lead & Director at Hanfeng Evergreen, Inc. Mr. Pollack is also on the board of 6 other companies. Mr. Pollack previously was Director & Executive Vice President at API Technologies Corp., Vice President & Founding Member at Violy Byorum & Partners, President for JMP Group, Inc. and Chief Financial Officer & Secretary at Kaboose, Inc. Mr. Pollack received a graduate degree from London School of Economics & Political Science and an undergraduate degree from McGill University.
Juergen H. L. Ernst Juergen H. L. Ernst is on the board of �0�1�6�9terna Zentaris, Inc. (former Chairman) and Pharming Group NV. In the past he occupied the position of General Manager-Pharmaceutical Sector at Solvay SA and Head-Pharmaceutical Division at Kali-Chemie AG (a subsidiary of Solvay SA). Juergen H. L. Ernst received an MBA from Universit�0�1¤t zu K�0�1�0�9ln and an undergraduate degree from Harvard University.
H. B. Brent Norton Founder of PreMD, Inc., H. B. Brent Norton is a businessperson who has been at the head of 5 different companies and currently is President, CEO, Director & Head-Investor Relations at this company and Venture Partner at Lumira Capital Investment Management, Inc. Dr. Norton is also on the board of �0�1�6�9terna Zentaris, Inc., Ontario Bioscience Industry Organization and Ortho Regenerative Technologies, Inc. (former President, Chief Executive Officer & Director) and Member of Advanced Technology Group USA, Inc. and Member of Richard Ivey School of Business Foundation. In the past he occupied the position of President & Chief Executive Officer at MedCurrent Corp., President, Chief Executive Officer & Director at Eyecarrot Innovations Corp., Treasurer & Director at Osler Bluff Ski Club Ltd., Chairman-Friends Project at The Canadian Institute for Advanced Research and Executive Director & Head-Investor Relations at Cotinga Pharmaceuticals, Inc. Dr. Norton received an MBA from the University of Western Ontario, a graduate degree from L'�0�1‰cole Polytechnique de Montr�0�1�0�8al and a doctorate from McGill University.
Leslie Auld Presently, Leslie Auld is Chief Financial Officer & Senior Vice President of �0�1�6�9terna Zentaris, Inc. In her past career she occupied the position of CFO, Treasurer & Non-Independent Director at GeneNews Ltd., Controller of Helix BioPharma Corp., Chief Financial Officer of Citation Resources, Inc., Chief Financial Officer at CNP Therapeutics, Inc. and Senior Director-Finance at Luminex Molecular Diagnostics, Inc. Leslie Auld received an MBA from the University of Toronto and an undergraduate degree from the University of Western Ontario.
Robin Smith Hoke Currently, Robin Smith Hoke is President & Chief Executive Officer at Leiter's Enterprises, Inc. Ms. Hoke is also on the board of �0�1�6�9terna Zentaris, Inc. In her past career she occupied the position of President-Commercial Operations & General Counsel at GeneraMedix Pharmaceuticals, Inc. and President at GeneraMedix, Inc. (a subsidiary of GeneraMedix Pharmaceuticals, Inc.), Partner at Kegler Brown Hill + Ritter Co. LPA, Senior Vice President-Global Business Development at Cardinal Health, Inc., In-House Counsel at Abbott Laboratories and Chairman for Concord Biosciences LLC. Robin Smith Hoke received an undergraduate degree from Michigan State University and a graduate degree from The Thomas M. Cooley Law School.
Carolyn Egbert Carolyn Egbert is Non-Executive Chairman of �0�1�6�9terna Zentaris, Inc. Dr. Egbert is also Member of State Bar of Michigan and Member of The District of Columbia Bar. In the past Dr. Egbert held the position of Senior Executive VP-Global Ethics & Compliance at Solvay America, Inc. She received an undergraduate degree from George Washington University, a graduate degree from Seattle University, a doctorate from Georgetown University School of Medicine and a doctorate from Feinberg School of Medicine.
Jude Dinges Mr. Jude Dinges is Chief Commercial Officer & Senior Vice President at �0�1�6�9terna Zentaris, Inc.
Carolyn Egbert Dr. Richard Sachse is Senior VP, Chief Scientific & Medical Officer at �0�1�6�9terna Zentaris, Inc. and a Managing Director at AEterna Zentaris GmbH. Dr. Sachse was previously employed as Vice President-Global Translational Medicine by Boehringer Ingelheim GmbH and Head-Experimental Medicine by UCB SA. He received his undergraduate degree from Friedrich-Alexander University of Erlangen-Nuremberg and a doctorate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Eckhard G. Guenther Eckhard G. Guenther is Vice President-Business Development for AEterna Zentaris GmbH and Vice President-Alliance Management at �0�1�6�9terna Zentaris, Inc. In the past Dr. Guenther held the position of Head-Research Coordination & Medicinal Chemistry at ASTA Medica AG. Eckhard G. Guenther received an undergraduate degree from Martin-Luther-Universit�0�1¤t Halle-Wittenberg.
Genevi�0�1¨ve Lemaire Ms. Genevi�0�1¨ve Lemaire, CPA, is Chief Accounting Officer & Vice President-Finance at �0�1�6�9terna Zentaris, Inc. He received his undergraduate degree from the University of Sherbrooke.
Michael V. Ward Presently, Michael V. Ward holds the position of President, CEO & Head-Media Relations at �0�1�6�9terna Zentaris, Inc. In his past career Mr. Ward was Senior Associate at K&R Law Group LLP, Partner at Outside GC LLC, Vice President-Corporate Development of AmerisourceBergen Corp., VP & Assistant General Counsel-Global Compliance at CDK Global, Inc., Vice President & General Counsel for ACCO Brands Corp., Chief Executive Officer at AEterna Zentaris GmbH, Secretary, Chief Legal & Compliance Officer at Sagent Pharmaceuticals, Inc., Secretary, Senior Vice President & General Counsel of Targus Group International, Inc. and Of Counsel at Arter & Hadden. Michael V. Ward received a graduate degree from Case Western Reserve University School of Law and an undergraduate degree from Albion College.
Michael Teifel Founder of Munich Biotech AG, Michael Teifel is Vice President-Non Clinical Services at AEterna Zentaris GmbH and Vice President-Non Clinical Sciences at �0�1�6�9terna Zentaris, Inc. In his past career Dr. Teifel was Head-Pharmacology & Toxicology at Munich Biotech AG. He received a doctorate from Technische Universit�0�1¤t Darmstadt.
Nicola Ammer Currently, Nicola Ammer holds the position of Chief Medical Officer & VP-Clinical Development at �0�1�6�9terna Zentaris, Inc. and Head-Clinical Development at AEterna Zentaris GmbH (a subsidiary of �0�1�6�9terna Zentaris, Inc.). She is also Head-Clinical Development at AEterna Zentaris GmbH. She previously occupied the position of Head-European Business Development Operations at Pierrel Research International AG. She received a graduate degree from the University of Duisburg-Essen.
Olaf Althaus Olaf Althaus is Managing Director & General Manager at �0�1�6�9terna Zentaris, Inc.
Brian Garrison Brian Garrison is SVP-Global Commercial Operations at �0�1�6�9terna Zentaris, Inc. In his past career Mr. Garrison held the position of Director-Oncology Reimbursement Marketing at Amgen, Inc. Mr. Garrison received an undergraduate degree from US Military Academy.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐